Emmanuel Cherem, a 25-year-old gay man in Nigeria, tested positive for HIV two months after U.S. President Donald Trump's administration cut access for at-risk groups like gay men and injecting drug ...

Gay men in Africa are blaming President Trump's decision to cut funding for HIV/AIDS prevention for their diagnoses of the virus. The administration's sweeping cuts to foreign aid have reduced ...

In East and Southern Africa, the sub-region that accounts for more than half of all people living with HIV, the U.S. had been funding nearly 45% of HIV prevention programming, UNAIDS said in March.

Introduction. In the United States, the HIV epidemic continues to affect African American and Latino men who have sex with men (MSM) disproportionately to their representation in the population.

U.S. funded treatments in the country have helped reduce deaths from HIV/AIDS to around 14,000 a year, from as high as 200,000.

According to the UNAIDS Spectrum Report 2024, approximately 360,000 people are currently living with HIV in Botswana.

Preventative therapies for HIV-1 (Human Immunodeficiency Virus type 1) have made leaps and bounds over the past decade. A ...

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...

The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that ...

In East and Southern Africa, the sub-region that accounts for more than half of all people living with HIV, the U.S. had been funding nearly 45% of HIV prevention programming, UNAIDS said in March.

(Reuters) -Emmanuel Cherem, a 25-year-old gay man in Nigeria, tested positive for HIV two months after U.S. President Donald Trump's administration cut access for at-risk groups like gay men and ...